Benzinga | Nov 15, 2021 11:03AM EST

Biodesix Q3 EPS $(0.41) Beats $(0.48) Estimate, Sales $6.50M Beat $6.17M Estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.48) by 14.58 percent. This is a 98.72 percent increase over losses of $(31.93) per share from the same period last year. The company reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.17 million by 5.35 percent. This is a 29.29 percent decrease over sales of $9.19 million the same period last year.